(Q33756604)

29 July 2017

1 reference

title

Unexplained aspects of anemia of inflammation (English)

1 reference

29 July 2017

0 references

Elizabeth A Price

1

1 reference

29 July 2017

Stanley L Schrier

series ordinal

2

1 reference

29 July 2017

publication date

24 March 2010

1 reference

29 July 2017

published in

Advances in Hematology

1 reference

29 July 2017

volume

2010

1 reference

29 July 2017

page(s)

508739

1 reference

Creative Commons Attribution 3.0 Unported

29 July 2017

copyright license

start time

1 January 2010

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

1 reference

April 2022 Public Data File from Crossref

cites work

Hepcidin--a potential novel biomarker for iron status in chronic kidney disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2846342

Regulation of hepcidin and iron-overload disease

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2846342

Plasma hepcidin levels are elevated but responsive to erythropoietin therapy in renal disease

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2846342

Iron metabolism in the anemia of chronic disease.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2846342

Unexplained anaemia in older persons is characterised by low erythropoietin and low levels of pro-inflammatory markers

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2846342

Hepcidin antimicrobial peptide transgenic mice exhibit features of the anemia of inflammation

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2846342

Suppression of hepcidin during anemia requires erythropoietic activity

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2846342

Interleukin-6 induces hepcidin expression through STAT3

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2846342

Interleukin-6 in aging and chronic disease: a magnificent pathway

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2846342

Detection of serum hepcidin in renal failure and inflammation by using ProteinChip System

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2846342

Proinflammatory state and circulating erythropoietin in persons with and without anemia

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2846342

Anemia of chronic disease.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2846342

Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2846342

IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2846342

Iron Deficiency and Erythropoiesis: New Diagnostic Approaches

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2846342

Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2846342

Advances in the anemia of chronic disease

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2846342

The anemia of chronic disorders

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2846342

Erythropoietin and erythropoiesis in anemic man following androgens

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2846342

Anemia of chronic disease in rheumatoid arthritis is associated with increased apoptosis of bone marrow erythroid cells: improvement following anti-tumor necrosis factor-alpha antibody therapy

21 June 2018

1 reference

https://api.crossref.org/works/10.1155%2F2010%2F508739

Chronic anemia and fatigue in elderly patients: results of a randomized, double-blind, placebo-controlled, crossover exploratory study with epoetin alfa

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2010%2F508739

Prevalence of anemia in persons 65 years and older in the United States: evidence for a high rate of unexplained anemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2010%2F508739

Effect of steroids on the cycling of haemopoietic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2010%2F508739

Etiology of anemia in patients with advanced heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2010%2F508739

Regulation of iron homeostasis in anemia of chronic disease and iron deficiency anemia: diagnostic and therapeutic implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2010%2F508739

Phlebotomies or erythropoietin injections allow mobilization of iron stores in a mouse model mimicking intensive care anemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2010%2F508739

Increased expression of erythropoiesis inhibiting cytokines (IFN-gamma, TNF-alpha, IL-10, and IL-13) by T cells in patients exhibiting a poor response to erythropoietin therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2010%2F508739

Alterations of systemic and muscle iron metabolism in human subjects treated with low-dose recombinant erythropoietin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2010%2F508739

High levels of GDF15 in thalassemia suppress expression of the iron regulatory protein hepcidin

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2010%2F508739

Bone marrow progenitor cell reserve and function and stromal cell function are defective in rheumatoid arthritis: evidence for a tumor necrosis factor alpha-mediated effect

21 January 2018

1 reference

12 December 2020

Treatment of primary defective iron-reutilization syndrome: revisited

1 reference

12 December 2020

High C-reactive protein is a strong predictor of resistance to erythropoietin in hemodialysis patients

1 reference

12 December 2020

Time-course analysis of hepcidin, serum iron, and plasma cytokine levels in humans injected with LPS

1 reference

12 December 2020

Primary defective iron reutilization. Response to testosterone therapy

1 reference

12 December 2020

The anemia of chronic disease: spectrum of associated diseases in a series of unselected hospitalized patients

1 reference

12 December 2020

Increase of plasma IL-6 concentration with age in healthy subjects

1 reference

12 December 2020

Blunted erythropoietin production and defective iron supply for erythropoiesis as major causes of anaemia in patients with chronic heart failure

1 reference

12 December 2020

Serum hepcidin concentration in chronic haemodialysis patients: associations and effects of dialysis, iron and erythropoietin therapy

1 reference

12 December 2020

Identifiers

DOI

10.1155/2010/508739

1 reference

29 July 2017

1 reference

29 July 2017

1 reference